#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this systematic review and meta-analysis that included 16,597 patients, fine needle biopsy (FNB) sensitivity was approximately 86%, and ...
1. Patients in the active surveillance group who had forgone surgery had no difference in survival compared to patients who ...
Click to read this study in the Journal of Clinical Oncology.
1. Patients with low-risk thyroid cancer undergoing thyroidectomy, who did not receive radioiodine post-operatively, did not show inferior functional, structural, ...
1. Multifocal papillary thyroid carcinoma (PTC) was associated with a higher risk of cancer recurrence than unifocal PTC. 2. Large ...
1. This ecological study found that from 1974 to 2013, there were average annual increases in incidence rates and mortality ...
1. The majority of benign thyroid nodules did not significantly increase in size during a 5-year follow-up period. 2. While ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. HIV-Positive-to-HIV-Positive ...
1. In a cohort of patients who were younger than 10 years of age at the time of radiation exposure ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.